医学
股骨头
病理生理学
疾病
炎症
外周血单个核细胞
生物信息学
内科学
外科
生物化学
生物
化学
体外
出处
期刊:Saudi Medical Journal
[Saudi Medical Journal]
日期:2022-11-01
卷期号:43 (11): 1192-1199
标识
DOI:10.15537/smj.2022.43.11.20220429
摘要
Osteonecrosis of the femoral head (ONFH) is the most prevalent musculoskeletal pathologic manifestation of sickle cell disease (SCD) resulting in an osteonecrotic event. This review aimed to summarize mechanisms involved in pathophysiology of ONFH and treatment options available in Saudi Arabia to treat SCD patients with complication of osteonecrotic event. The pathophysiology of ONFH include genetic and micro particles involvement. The progression of osteonecrosis involves reduced levels of bioactive compounds in peripheral blood mononuclear cells and elevated CD4+T circulating levels to stimulate pro-inflammatory cytokines contributing to inflammation at target site. Initial treatment approach is pharmacological agents use to mitigate risk. Further, bone morphogenetic protein stimulation initiate bone formation and treatment can be improved with the use of bone morphogenetic protein, total hip arthroplasty and cell therapies. This review provides baseline information for future studies to be carried out in Saudi Arabia to improve treatment options in SCD patients with ONFH.
科研通智能强力驱动
Strongly Powered by AbleSci AI